Baker Bros. Advisors LP Design Therapeutics, Inc. Put Options Transaction History
Baker Bros. Advisors LP
- $9.02 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding DSGN
# of Institutions
100Shares Held
31.5MCall Options Held
2.3KPut Options Held
2.7K-
Sr One Capital Management, LP6.53MShares$25.9 Million14.99% of portfolio
-
Logos Global Management LP San Francisco, CA4.22MShares$16.7 Million3.42% of portfolio
-
Black Rock Inc. New York, NY2.3MShares$9.15 Million0.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA1.89MShares$7.51 Million0.55% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.6MShares$6.35 Million0.02% of portfolio
About Design Therapeutics, Inc.
- Ticker DSGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,807,900
- Market Cap $222M
- Description
- Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...